Facebook
Twitter
LinkedIn
Forward120 Hepatocellular Carcinoma Conference (HCC) (111822)
Dallas, TX US
November 18, 2022
The multidisciplinary approach, including the medical, surgical, and radiation areas of cancer therapy, providing a forum for the comprehensive care of complex cases in the management of HCC Cancer Patients.
Target Audience
Faculty, Surgeons, Transplant Services, Radiologists, Gastroenterologists, and guests who are interested in the care of HCC patients.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Develop comprehensive plans for care in complex HCC Cases
- Identify clinical trials that would be appropriate for HCC Patients
- Incorporate multidisciplinary aspects in the care of HCC Patients
- Provide the target audience knowledge to achieve uniform care based on evidence based principles
UT Southwestern Medical Center
5323 Harry Hines Blvd.
De Paul Conference Room
Dallas, TX
75390
United States
Moderator(s)
Adam Yopp, Surgical Director, Liver Tumor Program
has no relevant financial relationships to disclose at this time.
Speaker(s)
Amit Singal, MD MS
has a financial relationship (Independent contractor) with Exact Sciences;.
has a financial relationship (Independent contractor) with Exelixis;.
has a financial relationship (Independent contractor) with Glycotest;.
has a financial relationship (Independent contractor) with AstraZeneca;.
has a financial relationship (Independent contractor) with Eisai;.
has a financial relationship (Independent contractor) with Roche;.
has a financial relationship (Independent contractor) with Wako Diagnostics;.
has a financial relationship (Independent contractor) with Bayer;.
has a financial relationship (Independent contractor) with GRAIL;.
has a financial relationship (Independent contractor) with Genentech;.
Adam Yopp, Surgical Director, Liver Tumor Program
has no relevant financial relationships to disclose at this time.
Available Credit
- 1.00 AMA
- 1.00 Attendance